Clinical Trial

CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a study of CDC-9 inactivated rotavirus vaccine (IRV) microneedle patch (MNP) for intradermal administration in healthy adults aged 18 to 45 years at two dose levels in a 3-dose series. The purpose is to determine if it is safe and if the recipient's immune system responds to the vaccine.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-30; most recent amendment 2026-03-04.
Status change: Recruiting → Active, Not Recruiting 2026-03-04
Status change: Not Yet Recruiting → Recruiting 2025-07-01
Trial Details
NCT Number NCT06962904
Lead Sponsor Centers for Disease Control and Prevention
Collaborators: Emory-Children's Center, Children's Hospital Medical Center, Cincinnati, Micron Biomedical, Inc
Conditions Rotavirus Infections
Enrollment 50 participants
Start Date 2025-07-07
Primary Completion 2026-10-06 (estimated)
Study Completion 2026-10-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-05